© 2001 by Oxford University Press
Journal of the National Cancer Institute, Vol. 93, No. 15, 1147-1152,
August 1, 2001
© 2001 Oxford University Press
REPORT |
Molecular Evidence for the Independent Origin of Extra-ovarian Papillary Serous Tumors of Low Malignant Potential
Affiliations of authors: J. Gu, L. M. Roth, C. Younger, H. Michael, S. Zhang, T. M. Ulbright, J. N. Eble, L. Cheng, Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis; F. W. Abdul-Karim, Case Western Reserve University School of Medicine, Cleveland, OH.
Correspondence to: Liang Cheng, M.D., Department of Pathology and Laboratory Medicine, Indiana University Medical Center, University Hospital 3465, 550 N. University Blvd., Indianapolis, IN 46202 (e-mail: lcheng{at}iupui.edu).
Background: Molecular data suggest that peritoneal tumors in women with advanced-stage ovarian papillary serous adenocarcinoma are monoclonal in origin. Whether the same is true for ovarian tumors of low malignant potential is not known. We compared peritoneal and ovarian tumors from women with advanced-stage ovarian papillary serous tumors of low malignant potential to determine whether the peritoneal tumors arose from the same clone as the ovarian tumors. Methods: We studied the clonality of 73 peritoneal and ovarian tumors from 18 women with advanced-stage ovarian papillary serous tumors of low malignant potential. Formalin-fixed, paraffin-embedded tumors and representative normal tissues were sectioned and stained with hematoxylineosin, representative sections from separate tumors were manually microdissected, genomic DNA was extracted from the microdissected tumors, and the polymerase chain reaction was used to amplify a CAG polymorphic site in the human androgen receptor locus on the X chromosome to determine the inactivation pattern of the X chromosome and the clonality of the tumors. Results: The pattern of X-chromosome inactivation could be determined from the tumors of 13 of 18 patients. Of the 13 patients, seven (54%) had nonrandom inactivation of the X chromosome, and six of the seven had different inactivation patterns in the peritoneal and ovarian tumors. Three of these patients also had different patterns of nonrandom X-chromosome inactivation in tumors from each ovary. The remaining six patients had random patterns of X-chromosome inactivation in the peritoneal and ovarian tumors. Conclusions: Our data suggest that peritoneal and ovarian tumors of low malignant potential arise independently.
This article has been cited by other articles:
![]() |
X. Wang, M. Wang, G. T. MacLennan, F. W. Abdul-Karim, J. N. Eble, T. D. Jones, F. Olobatuyi, R. Eisenberg, O. W. Cummings, S. Zhang, et al. Evidence for Common Clonal Origin of Multifocal Lung Cancers J Natl Cancer Inst, April 15, 2009; 101(8): 560 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cheng, G. T. MacLennan, S. Zhang, M. Wang, M. Zhou, P.-H. Tan, S. Foster, A. Lopez-Beltran, and R. Montironi Evidence for Polyclonal Origin of Multifocal Clear Cell Renal Cell Carcinoma Clin. Cancer Res., December 15, 2008; 14(24): 8087 - 8093. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Katona, T. D. Jones, M. Wang, F. W. Abdul-Karim, O. W. Cummings, and L. Cheng Molecular Evidence for Independent Origin of Multifocal Neuroendocrine Tumors of the Enteropancreatic Axis. Cancer Res., May 1, 2006; 66(9): 4936 - 4942. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. McCarthy, M. Wang, T. D. Jones, R. W. Strate, and L. Cheng Molecular Evidence for the Same Clonal Origin of Multifocal Papillary Thyroid Carcinomas Clin. Cancer Res., April 15, 2006; 12(8): 2414 - 2418. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Jones, J. N. Eble, M. Wang, G. T. MacLennan, B. Delahunt, M. Brunelli, G. Martignoni, A. Lopez-Beltran, S. M. Bonsib, T. M. Ulbright, et al. Molecular Genetic Evidence for the Independent Origin of Multifocal Papillary Tumors in Patients with Papillary Renal Cell Carcinomas Clin. Cancer Res., October 15, 2005; 11(20): 7226 - 7233. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.-M. Shih and R. J. Kurman Molecular Pathogenesis of Ovarian Borderline Tumors: New Insights and Old Challenges Clin. Cancer Res., October 15, 2005; 11(20): 7273 - 7279. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Jones, M. Wang, J. N. Eble, G. T. MacLennan, A. Lopez-Beltran, S. Zhang, A. Cocco, and L. Cheng Molecular Evidence Supporting Field Effect in Urothelial Carcinogenesis Clin. Cancer Res., September 15, 2005; 11(18): 6512 - 6519. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cheng, T. D. Jones, R. P. McCarthy, J. N. Eble, M. Wang, G. T. MacLennan, A. Lopez-Beltran, X. J. Yang, M. O. Koch, S. Zhang, et al. Molecular Genetic Evidence for a Common Clonal Origin of Urinary Bladder Small Cell Carcinoma and Coexisting Urothelial Carcinoma Am. J. Pathol., May 1, 2005; 166(5): 1533 - 1539. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. X. Liang, S. K. Chambers, L. Cheng, S. Zhang, Y. Zhou, and W. Zheng Endometrial Glandular Dysplasia: A Putative Precursor Lesion of Uterine Papillary Serous Carcinoma. Part II: Molecular Features International Journal of Surgical Pathology, October 1, 2004; 12(4): 319 - 331. [Abstract] [PDF] |
||||
![]() |
R. P. McCarthy, S. Zhang, D. G. Bostwick, J. Qian, J. N. Eble, M. Wang, H. Lin, and L. Cheng Molecular Genetic Evidence for Different Clonal Origins of Epithelial and Stromal Components of Phyllodes Tumor of the Prostate Am. J. Pathol., October 1, 2004; 165(4): 1395 - 1400. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Kernek, T. M. Ulbright, S. Zhang, S. D. Billings, O. W. Cummings, J. D. Henley, H. Michael, M. Brunelli, G. Martignoni, R. S. Foster, et al. Identical Allelic Losses in Mature Teratoma and Other Histologic Components of Malignant Mixed Germ Cell Tumors of the Testis Am. J. Pathol., December 1, 2003; 163(6): 2477 - 2484. [Abstract] [Full Text] |
||||
![]() |
P. Morice, A. Thoury, J.C. Sabourin, S. Camatte, D. Atallah, J.P. Armand, P. Madelenat, P. Duvillard, and D. Castaigne Unusual Abdominal and Pelvic Tumors: CASE 2. SPONTANEOUS REGRESSION OF PERITONEAL IMPLANTS IN BORDERLINE OVARIAN TUMOR AFTER SALPINGO-OOPHORECTOMY J. Clin. Oncol., September 15, 2003; 21(18): 3536 - 3538. [Full Text] [PDF] |
||||
![]() |
N. L.G. Sieben, S. M. Kolkman-Uljee, A. M. Flanagan, S. le Cessie, A.-M. Cleton-Jansen, C. J. Cornelisse, and G. J. Fleuren Molecular Genetic Evidence for Monoclonal Origin of Bilateral Ovarian Serous Borderline Tumors Am. J. Pathol., April 1, 2003; 162(4): 1095 - 1101. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Gardner and M. J. Birrer Ovarian Tumors of Low Malignant Potential: Can Molecular Biology Solve This Enigma? J Natl Cancer Inst, August 1, 2001; 93(15): 1122 - 1123. [Full Text] [PDF] |
||||





